CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Access 2 Care

Access 2 Care is a Lincoln Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Air Liquide Healthcare America Corporation

Air Liquide Healthcare America Corporation is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Signature MD

Through concierge medicine, SignatureMD creates doctor-patient partnerships that are based on extraordinary understanding and trust.

NeoLife International

NeoLife is a pioneer in whole food nutrition supplementation since 1958, with a commitment to end the trend of poor wellness and poverty.

Mary Ann Morse Healthcare Center

Non-profit Mary Ann Morse Healthcare Corp. provides continuum of affordable, quality senior living and healthcare services in Metro West.